Docosahexaenoic acid (DHA) is the predominant omega‐3 long‐chain polyunsaturated fatty
acid found in human brain and eyes. There are a number of studies in the literature showing …

Supplements have reached a prominent role in improving the supply of long-chain omega-3
fatty acids, such as Eicosapentaenoic acid (EPA 20: 5 n− 3) and Docosahexaenoic acid …

Docosahexaenoic acid (DHA) is important for brain function, and can be obtained directly
from the diet or synthesized in the body from α-linolenic acid (ALA). Debate exists as to …

Alzheimer's disease (AD) is generally associated with lower omega-3 fatty acid intake from
fish but despite numerous studies, it is still unclear whether there are differences in omega-3 …

Background The erythrocyte membrane content of eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA), which constitutes the omega‐3 index (O3I), predicts …

Cognitive decline in the elderly, particularly Alzheimer's disease (AD), is a major socio-
economic and healthcare concern. We review here the literature on one specific aspect of …

This review considers the bioavailability of different forms of omega-3 long chain
polyunsaturated fatty acids (n-3 LC-PUFA), including ethyl esters (EEs), free fatty acids …

Background: There is a debate currently about whether different chemical forms of
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are absorbed in an identical …

BACKGROUND: The fatty acid (FA) composition of the red blood cell (RBC) has been
reported to provide prognostic information regarding risk for coronary heart disease (CHD) …

Numerous health benefits are attributed to the n-3 long-chain PUFA (n-3 LCPUFA); EPA and
DHA. A systematic literature review was conducted to investigate factors, other than diet, that …